More on INTS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1,500.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Intensity Therapeutics (NQ:INTS)
Delayed: 4.10 +0.10 (2.50%)
Prev. Close $4.00  
Open$3.99 
52 Wk High$ 
52 Wk Low$ 
Day High$4.11 
Day Low$3.99 
P/E N/A  
EPS$ 
Volume4,450 

Friends, Peers and Foes (?): NTHI TNGX (more...)

Aug 19, 2026 06:46 AM H.C. Wainwright Reiterates Buy Rating on Intensity Therapeutics, Inc. (INTS)
Aug 11, 2026 11:01 AM NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float
Aug 11, 2026 08:01 AM Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 24c
Aug 11, 2026 07:41 AM Form 8-K INTENSITY THERAPEUTICS, For: Aug 11
Aug 11, 2026 07:30 AM Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 11, 2026 07:17 AM Form 10-Q INTENSITY THERAPEUTICS, For: Jun 30
Aug 4, 2026 08:00 AM Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026
Jul 20, 2026 04:04 PM Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: DUBIN THOMAS I H
Jul 20, 2026 04:04 PM Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: Donovan Daniel
Jul 20, 2026 04:04 PM Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: GOLDBERG MARK A
View All Articles

Entities mentioned with INTS

View All Entities